The Covid-19 pandemic resulted in our shutting down in-person biofeedback and neurofeedback services for periods of time. We anticipated this and developed remote platforms for delivering these services. The necessary equipment and software can be leased from us, and we provide technical assistance and supervision at a reasonable cost.
There are many advantages to doing home training. During the pandemic, there is no risk of infection if you stay home and receive treatment remotely. You don’t have to come to the office or fit into our schedule quite as much. Because you have the equipment and software in your home, you can train whenever you want and as many times as you want. Typically, in-office treatments are weekly. Most people simply cannot find the time or have the money to do twice-weekly sessions despite the fact that the effects of training are not seen nearly as quickly when you only train once a week. In sum, remote training is safe, convenient, and efficient.
We are offering three levels of biofeedback and neurofeedback programs for remote training. Counselling and support remain integral components at each of these levels. The first level, Neuroshaping Starter, employs a consumer EEG device called the Muse, which can be used to improve attention and develop meditation skills. The second level, Neuroshaping Lyte, uses the Muse with an additional electrode and software for targeted neurofeedback. The third level, Neuroshaping Pro, uses professional equipment and software for fully functional biofeedback and neurofeedback treatment.
To sum up, there are three Neuroshaping platforms available for doing biofeedback and neurofeedback remotely. The cost of support from us is similar to having weekly visits in the office and should be covered by insurance in an equivalent way. The added cost for the Lyte and Pro platforms is for the equipment and software. This cost may be covered by some forms of insurance.
Please give us a call if you are interested (705-874-7125), and we can provide you with more detail about the platforms and costs.